Additional information
| Active substance | Levocetirizine |
|---|---|
| Water Retention | Negligible |
| Hepatotoxicity | Low |
| Lab Test | Not routinely required |
| Strength | 5mg |
| Also known as | Levocetirizine dihydrochloride |
| Blood pressure | Generally does not affect blood pressure significantly |
| Trade name | Xyzal |
| Storage conditions | Store at room temperature, away from excess heat and moisture |
| Chemical name | (R)-2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic acid |
| Formula | C21H25ClN2O3 |
| Substance class | Antihistamine |
| Main action | H1 histamine receptor antagonist |
| Half-life | 6 to 10 hours |
| Dosage (medical) | 5 mg once daily |
| Dosage (sports) | Not applicable |
| Effects | Relief from allergic symptoms such as sneezing, runny nose, itchy or watery eyes, and hives |
| Side effects | Drowsiness, fatigue, dry mouth, headaches |
| Use in sports | No specific use in sports |
| Manufacturer | Cipla Ltd. |
| Packing | 10 tabs/blister |
Champix Starter Pack Pfizer
Spiriva HandiHaler 18mg Boehringer Ingelheim
FUCIDIN 500 mg Abdi Ibragim
Norvacs 10 mg Pfizer
Fostimon (Merional) 150 IU HMG IBSA
Januvia 100mg Merckgroup 


Reviews
There are no reviews yet.